ACLY and hepatocellular carcinoma: Given the role of AMPK in pro-survival signalling38 and the compensatory upregulation of ACSS2 upon ACLY inhibition8,9,12, these findings highlight key mechanistic differences between EVT0185 and bempedoic acid and supported continued development of EVT0185 for HCC.